Back to Search Start Over

Defining the pathogenicity of creatine deficiency syndrome

Authors :
Pedro Ruiz-Sala
Rafael Artuch
Begoña Merinero
Eva Richard
Magdalena Ugarte
Jaume Campistol
Pilar Rodríguez-Pombo
Antonia Ribes
Angela Arias
Patricia Alcaide
Rosa Navarrete
Centro de Diagnóstico de Enfermedades Moleculares, Dpto. Biol. Mol. Centro de Biología Molecular-SO UAM-CSIC. Universidad Autónoma Madrid, Campus Cantoblanco
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Car
CIBER de Enfermedades Raras (CIBERER)
Instituto de Salud Carlos III [Madrid] (ISC)
Source :
Human Mutation, Human Mutation, Wiley, 2011, 32 (3), pp.282. ⟨10.1002/humu.21421⟩
Publication Year :
2010

Abstract

This work examined nine patients with creatine deficiency syndrome (CDS): six with a creatine transport (CRTR) defect and three with a GAMT defect. Eleven nucleotide variations were detected: six in SLC6A8 and five in GAMT. These changes were analyzed at the mRNA level and specific alleles (most of which bore premature stop codons) were selected as nulls because they provoked nonsense-mediated decay activation. The impact of these CDS mutations on metabolic stress (ROS production, p38MAPK activation, aberrant proliferation and apoptosis) was analyzed in patient fibroblast cultures. Oxidative stress contributed toward the severe form of CDS, with increases seen in the intracellular ROS content and the percentage of apoptotic cells. An altered cell cycle was also seen in a number of CRTR and GAMT fibroblast cell lines (mostly those carrying null alleles). p38MAPK activation only correlated with oxidative stress in the CRTR cells. Based on intracellular creatine levels, the contribution of energy depletion toward metabolic stress was demonstrable only in selected CRTR cells. Together, these findings suggest that the apoptotic response to genotoxic damage in the present CDS cells may have been triggered by different cell signaling pathways. They also suggest that reducing oxidative stress could be helpful in treating CDS. Hum Mutat 32:1-10, 2011. © 2011 Wiley-Liss, Inc.

Details

ISSN :
10981004 and 10597794
Volume :
32
Issue :
3
Database :
OpenAIRE
Journal :
Human mutation
Accession number :
edsair.doi.dedup.....e084b6ec01c37fe960d676837f643e94
Full Text :
https://doi.org/10.1002/humu.21421⟩